Catalog No.
RHD38002
Species reactivity
Human
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
ELISA: 1:10000, FCM: 1:200-1:400, IF: 1:200-1:1000, IHC: 1:200-1:1000, WB: 1:500-1:2000
Target
TF2D, TATA-binding factor, GTF2D1, Transcription initiation factor TFIID TBP subunit, TFIID, TBP, TATA sequence-binding protein, TATA-box factor, TATA-box-binding protein
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P20226
Applications
ELISA, FCM, IF, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R3F54
Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial., PMID:40450141
Clinical benefit of continuation of PD-1 inhibitors after progression on first-line chemoimmunotherapy in metastatic gastric cancer and biomarker exploration., PMID:40413463
Mistakes to avoid in the management of abdominal tuberculosis., PMID:39953910
AIEgen-self-assembled nanoparticles with anti-PD-L1 antibody functionalization realize enhanced synergistic photodynamic therapy and immunotherapy against malignant melanoma., PMID:39742147
The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression., PMID:39662097
Microbial community composition in subgingival plaques and heterogeneity of tumor tissue TCRβ CDR3 repertoire in patients with moderate-to-severe periodontitis and oral squamous cell carcinoma., PMID:39331118
Tick exposure biomarkers: A One Health approach to new tick surveillance tools., PMID:39286798
Seropositivity to tick-borne pathogens in nature management workers in the Netherlands., PMID:39277996
Hyper-late major response after 5 years of nivolumab: role of treatment beyond progression in head and neck cancer., PMID:38941120
Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08)., PMID:38285067
Evaluation of the Effect of Pb Pollution on Avian Influenza Virus-Specific Antibody Production in Black-Headed Gulls (Chroicocephalus ridibundus)., PMID:37508115
Progression patterns and site-specific responses in advanced gastric cancer patients treated with nivolumab., PMID:36789624
A novel co-culture assay to evaluate the effects of sympathetic innervation on vascular smooth muscle differentiation., PMID:36731293
Promoters of genes encoding β-amylase, albumin and globulin in food plants have weaker affinity for TATA-binding protein as compared to non-food plants: in silico analysis., PMID:36694715
Differential detection of tick-borne pathogens in human platelets and whole blood using microfluidic PCR., PMID:36435213
Phosphorous Dendron Micelles as a Nanomedicine Platform for Cooperative Tumor Chemoimmunotherapy via Synergistic Modulation of Immune Cells., PMID:36300810
First molecular detection of Mycoplasma ovis in horses from Brazil., PMID:36162457
The impact of zirconium-89 solution formulation on the efficiency of [89 Zr]Zr-deferoxamine synthesis., PMID:36138551
Pearson's principle-inspired hollow metal sulfide for amplified photoelectrochemical immunoassay for disease-related protein., PMID:35718654
Clinical Aspects and Detection of Emerging Rickettsial Pathogens: A "One Health" Approach Study in Serbia, 2020., PMID:35154030
TBP and SNAP50 transcription factors bind specifically to the Pr77 promoter sequence from trypanosomatid non-LTR retrotransposons., PMID:34108018
A simple protocol to purify human TFIID free of the MED26 subunit of mediator complex., PMID:33836240
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab., PMID:33743112
Sero-epidemiology of porcine parvovirus, circovirus, and classical swine fever virus infections in India., PMID:33624145
Comparison of Anaplasma and Ehrlichia species-specific peptide ELISAs with whole organism-based immunofluorescent assays for serologic diagnosis of anaplasmosis and ehrlichiosis in dogs., PMID:33369490
Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer., PMID:32661824
Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population., PMID:32223744
Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study)., PMID:32208960
Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo., PMID:31923538
TATA-Box Binding Protein O-GlcNAcylation at T114 Regulates Formation of the B-TFIID Complex and Is Critical for Metabolic Gene Regulation., PMID:31866147
Periplasmic binding protein-based magnetic isolation and detection of thiamine in complex biological matrices., PMID:31450459
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial., PMID:31246283
Label free phosphate functionalized semiconducting polymer dots for detection of iron(III) and cytochrome c with application to apoptosis imaging., PMID:31220724
Promoter Genotyping and mRNA Expression - Based Analysis of the PTGDR Gene in Allergy., PMID:31062691
Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression., PMID:30910574
Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab., PMID:30333065
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study., PMID:30217492
Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer., PMID:30124494
Comparison between laparoscopy and laboratory tests for the diagnosis of tuberculous peritonitis., PMID:30114349
Seroprevalence of bluetongue and presence of viral antigen and type-specific neutralizing antibodies in goats in Tripura, a state at Indo-Bangladesh border of northeastern India., PMID:30019245
Pathogenic characterization of porcine reproductive and respiratory syndrome virus of Indian origin in experimentally infected piglets., PMID:29790662
Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated With Immunotherapy., PMID:29668571
Imaging of native transcription factors and histone phosphorylation at high resolution in live cells., PMID:29440513
Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma., PMID:29266761
Reduced Nrf2 activation in PI3K phosphorylation-impaired vitiliginous keratinocytes increases susceptibility to ROS-generating chemical-induced apoptosis., PMID:28836394
Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials., PMID:28662232
Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025., PMID:28410865
Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer., PMID:28396358
Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse model., PMID:28161682
Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar disease., PMID:27957507
For research use only. Not for human or drug use.
